Abstract:The Ocean, which is called the 'mother of origin of life', is also the source of structurally unique natural products that are mainly accumulated in living organisms. Several of these compounds show pharmacological activities and are helpful for the invention and discovery of bioactive compounds, primarily for deadly diseases like cancer, acquired immuno-deficiency syndrome (AIDS), arthritis, etc., while other compounds have been developed as analgesics or to treat inflammation, etc. The lifesaving drugs are mainly found abundantly in microorganisms, algae and invertebrates, while they are scarce in vertebrates. Modern technologies have opened vast areas of research for the extraction of biomedical compounds from oceans and seas.

No abstract

No abstract

Background and Aim: African swine fever is one of the severe pathogens of swine. It has a significant impact on production and economics. So far, there are no known remedies, such as vaccines or drugs, reported working successfully. In the present study, the natural oil blend formulation's (NOBF) efficacy was evaluated against ASFV in vitro using porcine alveolar macrophages (PAMs) cells of swine. Materials and Methods: The capacity of NOBF against the ASFV was tested in vitro. The NOBF combines Eucalyptus globulus, Pinus sylvestris, and Lavandula latifolia. We used a 2-fold serial dilution to test the NOBF formulation dose, that is, 105 HAD50/mL, against purified lethal dose of African swine in primary PAMs cells of swine. The PAM cells survival, real-time polymerase chain reaction (PCR) test, and hemadsorption (HAD) observation were performed to check the NOBF efficacy against ASFV. Results: The in vitro trial results demonstrated that NOBF up to dilution 13 or 0.000625 mL deactivates the lethal dose 105 HAD50 of ASFV. There was no HAD (Rosetta formation) up to dilution 12 or 0.00125 mL of NOBF. The Ct value obtained by running real-time PCR of the NOBF group at 96 h post-infection was the same as the initial value or lower (25), whereas the Ct value of positive controls increased several folds (17.84). Conclusion: The in vitro trial demonstrated that NOBF could deactivate the ASFV. The NOBF has the potential to act as anti-ASFV agent in the field. The next step is to conduct in vivo level trial to determine its efficacy.

Infectious Myonecrosis Virus (IMNV) was first reported in Indonesia in 2006. By 2009, it spread all over the significant shrimp farming areas in Indonesia. There was a significant drop in shrimp production due to IMNV outbreak. Several efforts were made to understand the nature, mode of disease progression, and minimize the virus load. The IMNV progression was divided into four stages. Chemicals, especially of chlorine origin, showed protection against IMNV. Tilapia came up with an effective biological remedy against IMNV. The blend of essential oils, pondguard showed significant protection against IMNV in the laboratory and farms.

A formulation was developed using combination of blended natural essential oils as an antiVibrio parahemolyticus causing acute hepatopancreatic necrosis disease (AHPND) candidate. Lavandula latifolia, Pinus sylvestris, Jasminum officinale, Citrus limon, Prunus avium, Viola odorata, Gardenia jasminoides, Cocos nucifera, Rosa damascene and Eucalyptus globulus, mixed together to develop as anti-V. parahemolyticus product. The treatment group was fed on essential oil mixed feed whereas control group were fed on the regular feed throughout the experiment. The shrimp of both treatment and control were challenged by immersion method at day 8. The cumulative AHPND-gross sign appearance in positive control reached up to 95% at dpi 10 whereas no gross sign appeared in treatment and in negative control. The cumulative mortality reached up to 46.7% at dpi 10 in positive controls whereas no mortality recorded in treatment and in negative control. The V. parahaemolyticus isolated from the hepatopancreas of infected shrimp matched 100% with the existing AHPND strain. The trial results show that the developed natural herbal formulation has significant effect against AHPND in a controlled condition.

The potentiality of injection vaccine against white spot syndrome virus (WSSV) in crayfish Procambarus clarkii was investigated. WSSV envelope proteins VP19 and VP28 were expressed in yeast Pichia pastoris GS115. The purified recombinant proteins (2 µg/g of crayfish) were injected intramuscularly, and the same dose injected as a booster shot on fifth day after vaccination. The vaccinated crayfish were divided into two even groups and later challenged orally by WSSV-infected dead crayfish muscle (2 g/individual) on the third and 21st days after the booster shot. The relative percent survival (RPS) in the third-day group was the highest in VP28 (91%), followed by VP19 + VP28 (84%), and VP19 (45%). The RPS for the 21st-day group was the highest in VP28 (78%), followed by VP19 + VP28 (76%), and VP19 (17%). Development of vaccine by using recombinant proteins VP19 and VP28 expressed in yeast is feasible.

No abstract